Study, Evaluating Pharmacokinetics, Pharmacodynamics, Immunogenicity and Safety Profiles of Rituximab Compared to MabThera® in Patients With Rheumatoid Arthritis
Clinical trial NCT06175338 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06175338
- Sponsor
- Mabscale, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-14
- Primary completion
- 2024-11-01
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.